Mr. Greg Crawford reports

QUIPT HOME MEDICAL RECEIVES CONDITIONAL APPROVAL TO GRADUATE TO THE TORONTO STOCK EXCHANGE

Quipt Home Medical Corp. has received conditional approval from the Toronto Stock Exchange to graduate its listing from the TSX Venture Exchange to the TSX.

"Graduating to the Toronto Stock Exchange is a significant accomplishment, and I want to thank all our team members and shareholders for their ongoing support. Our ability to uplist demonstrates the evolution of our organization through the years and the ongoing momentum across the business in real time as we strive to become a national leader in respiratory care throughout the United States," said Greg Crawford, chairman and chief executive officer of Quipt. "This uplisting is an important step towards improving liquidity and increasing our investor audience in North America and abroad. Given the continued financial and operational success, this uplisting, and our effort to inform investors of our robust growth, have us extremely optimistic about the future."

Final approval of the listing is subject to the company meeting certain customary conditions required by the TSX. The company is working diligently to satisfy such listing conditions. Further details and a timeline for graduation will be announced in due course. Upon satisfaction of the TSX listing conditions, Quipt's common shares will be delisted from the TSX Venture Exchange.

Shareholders are not required to exchange their share certificates or take any other action in connection with the TSX listing, as there will be no change in the trading symbol or Cusip for the common shares. The company will continue to trade its common shares on the Nasdaq in the United States under the symbol QIPT.

About Quipt Home Medical Corp.

The company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States health care market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient.

We seek Safe Harbor.